SPOTLIGHT -
FDA Grants Breakthrough Therapy Designation for Pimicotinib in TGCT
Somaiah Shares Insight on the Changing Landscapes of GIST, TGCT, and RAS/RAF-Mutant Tumors
INT230-6 Alone, With Ipilimumab Induces Positive OS Results in Metastatic Sarcomas
Bekaii-Saab, George, and von Mehren Discuss Pivotal Findings in GIST, TGCT, and RAS/RAF–Mutated Solid Tumors
Randall Highlights Advances in Reconstruction Techniques for Patients With Bone Sarcomas
Radiation Therapy Plus Surgery May Improve Local Control in Localized Pelvic Ewing Sarcoma
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)